GITR drives TH9-mediated antitumor immunity

Il-Kyu Kim1, Yeonseok Chung2, Chang-Yuil Kang1

  • 1Laboratory of Immunology, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Republic of Korea; Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.

Oncoimmunology
|July 29, 2016
PubMed

Related Concept Videos